| Insurance Industry | Financials Sector | Mr. Zhao Lu CEO | HKEX Exchange | CNE100006M66 ISIN |
| China Country | 783 Employees | - Last Dividend | - Last Split | - IPO Date |
Zhejiang Taimei Medical Technology Co., Ltd., established in 2013 and based in Jiaxing, China, is at the forefront of digital transformation in the biopharma industry within China. The company specializes in developing a comprehensive digital operation platform named TrialOS, aimed at enhancing cooperation across various segments of the pharmaceutical industry. This includes hospitals, pharmaceutical companies, regulatory authorities, patients, and other stakeholders. Zhejiang Taimei leverages big data technology and an array of software solutions to streamline clinical trials, regulatory compliance, patient management, and pharmaceutical marketing, thereby facilitating better decision-making and operational efficiencies across the biopharma ecosystem.